Risk perceptions and ethical public health policy: MMR vaccination in the UK

Poiesis und Praxis

Volumn 3, Issue 4, 2005, Pages 229-241

  Dawson, Angus ^a  

^a KEELE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 30044431910     PISSN: 16156609     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10202-005-0002-3     Document Type: Article

References (25)

1. Bayer R, Fairchild A (2004) The genesis of public health ethics. Bioethics 18(6):473-492 10.1111/j.1467-8519.2004.00412.x
2. Cullity G (1995) Moral free riding. Philos Public Aff 24(1):3-34
3. Dawson A (2004) What should we do about it? implications of the empirical evidence in relation to comprehension and acceptability of randomisation. In: Holm S, Jonas M (Tds) Engaging the world: the use of empirical research in bioethics and the regulation of biotechnology. IOS Press, Netherlands
4. Dawson A (2005a) The determination of "Best Interests" in relation to childhood vaccinations. Bioethics 19(2):188-205 15945159
5. Dawson A (2005b) Herd protection as a public good: Vaccination and our obligations to others. In: Dawson A, Verweij M (eds) Ethics, prevention and public health. Oxford University Press, Oxford (in press)
6. Department of Health (1998) Communicating about risks to public health. Department of Health, London
7. Elliman D, Bedford H (2001) MMR vaccine: The continuing saga. BMJ 322:183-184 10.1136/bmj.322.7280.183
8. Garrard E, Dawson A (2005) What is the role of the REC? paternalism, inducements and harm in research ethics. J Med Ethics (in press)
9. Hargreaves I, Lewis J, Speers T (2003) Towards a better map: Science, the public and the media. ESRC, Swindon
10. Heller T (2001) Ethical debate: Vaccination against mumps, measles,& rubella: Is there a case for deepening the debate? BMJ 323:838-840 10.1136/bmj.323.7317.838
11. Jarmulowicz M (2002) Single measles vaccine should be allowed. BMJ 324:733 10.1136/bmj.324.7339.733
12. Klosko G (1987) Presumptive benefit, fairness and political obligation. Philos Public Aff 16(3):241-259
13. Madsen K et al (2002) A population-based study of measles, mumps and rubella vaccination and autism. NEJM 347(19):1477-1482 10.1056/ NEJMoa021134
14. NHS (2003-2004) NHS immunisation statistics, England. Bulletin 2004/16, London
15. Patja A et al (2000) Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up. Pediatr Infect Dis J 19(12):1127-1134 11144371
16. Paul Y (2004) Letter: Herd immunity and herd protection. Vaccine 22:301-302 10.1016/j.vaccine.2003.07.016
17. Peltola H, Heinonen O (1986) Frequency of true adverse reactions in measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins. Lancet 1:939-942 10.1016/S0140-6736(86)91044-5
18. Rawls J (1971) A theory of justice. Oxford University Press, Oxford
19. Smeeth L et al (2004) MMR vaccination and pervasive developmental disorders: A case-control study. Lancet 364:963-969 10.1016/ S0140-6736(04)17020-7
20. Tversky A, Kahneman D (1981) The framing of decisions and the psychology of choice. Science 211:453-458 7455683
21. Tversky A, Kahneman D (1984) Choices, values and frames. Am Psychol 39:341-350 10.1037//0003-066X.39.4.341
22. Verweij M, Dawson A (2004) Ethical principles for collective immunisation programmes. Vaccine 22:3122-3126 10.1016/ j.vaccine.2004.01.062
23. Verweij M, Dawson A (2005) What is meant by "public" in public health? In: Dawson A, Verweij M (eds) Ethics, prevention and public health. Oxford University Press, Oxford (in press)
24. Wakefield A et al (1998) Ileal-lymphoid-nodular hyperplasia, non-specific colitis and pervasive developmental disorder in children. Lancet 351:637-641 10.1016/S0140-6736(97)11096-0
25. Wakefield A, Montgomery S (2000) Measles, mumps and rubella vaccine: through a glass, darkly. Adverse drug react. Toxicol Rev 19(4):265-283 11212459